Intervention

adjuvant therapy

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 97 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials97

Recruiting0

Common conditions25

Lead sponsors shown15

Clinical trials

60 shown

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerNCT01407770 · 2011-09-20

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or SertralineNCT00667121 · 2011-03-16

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After SurgeryNCT01079793 · 2010-05-26

Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast CancerNCT01104571 · 2010-04-01

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast CancerNCT00902668 · 2009-04-01

Trastuzumab in Treating Older Women With Early-Stage Breast CancerNCT00796978 · 2009-02-05

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307NCT00873808 · 2008-10-01

TC Avastin. ICORG 08-10, V6NCT00911716 · 2008-10-01

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate CancerNCT00667069 · 2008-04-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast CancerNCT00629278 · 2007-12-01

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the BreastNCT00602628 · 2007-11-01

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryNCT00541047 · 2007-11-01

Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon CancerNCT00873600 · 2007-10-01

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryNCT00513266 · 2007-06-01

Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast CancerNCT00527293 · 2007-06-01

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryNCT00436566 · 2007-03-16

Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by SurgeryNCT00410683 · 2007-02-01

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast CancerNCT00516425 · 2007-01-01

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerNCT00423475 · 2006-10-01

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryNCT00398489 · 2006-10-01

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast CancerNCT00533936 · 2006-09-01

Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by SurgeryNCT00389688 · 2006-08-01

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerNCT00436709 · 2006-07-01

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast CancerNCT00354640 · 2006-06-01

Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By SurgeryNCT00373191 · 2006-05-01

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By SurgeryNCT00381901 · 2006-05-01

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)NCT00499083 · 2006-05-01

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryNCT00424203 · 2006-01-01

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryNCT00301925 · 2005-12-16

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate CancerNCT00376792 · 2005-10-01

Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerNCT00296010 · 2005-08-01

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerNCT00182793 · 2005-07-01

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNCT00227539 · 2005-07-01

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaNCT00227630 · 2005-07-01

Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNCT00248495 · 2005-06-08

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerNCT00398385 · 2005-05-01

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By SurgeryNCT00253409 · 2005-05-01

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung CancerNCT00113386 · 2005-04-01

Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate CancerNCT00607932 · 2005-03-01

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerNCT00098917 · 2005-02-01

Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast CancerNCT00602108 · 2005-01-01

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast CancerNCT00599989 · 2005-01-01

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerNCT00288002 · 2005-01-01

Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After SurgeryNCT00562718 · 2004-09-01

Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By SurgeryNCT00281970 · 2004-08-01

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast CancerNCT00427245 · 2004-08-01

Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast CancerNCT00104702 · 2004-07-01

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00091156 · 2004-05-01

Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung CancerNCT00274898 · 2004-05-01

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or AnastrozoleNCT00077168 · 2004-04-01

Radiation Therapy in Treating Women With Invasive Breast CancerNCT00301041 · 2004-04-01

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast CancerNCT00244959 · 2004-01-01

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryNCT00311636 · 2003-09-01

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast CancerNCT00072020 · 2003-08-01

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast CancerNCT00072319 · 2003-08-01

ZD6474 in Treating Patients With Small Cell Lung CancerNCT00066313 · 2003-05-01

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast CancerNCT00433420 · 2003-04-01

ACTIVE_NOT_RECRUITING

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerNCT00053911 · 2002-11-01

Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast CancerNCT00054301 · 2002-11-01

Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast CancerNCT00647582 · 2002-10-01

Common conditions

Leading sponsors

Case Comprehensive Cancer Center7 Mayo Clinic6 European Organisation for Research and Treatment of Cancer - EORTC5 Institute of Cancer Research, United Kingdom5 UNICANCER5 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4 Radiation Therapy Oncology Group3 SWOG Cancer Research Network3 University Hospital Birmingham3 Cancer Research Campaign Clinical Trials Centre2 City of Hope Medical Center2 GERCOR - Multidisciplinary Oncology Cooperative Group2 Memorial Sloan Kettering Cancer Center2 Roswell Park Cancer Institute2 University of California, San Francisco2

Trial status mix

COMPLETED53

UNKNOWN26

TERMINATED8

WITHDRAWN8

ACTIVE_NOT_RECRUITING1

SUSPENDED1

Phase mix

PHASE246

PHASE337

NA6

PHASE14

EARLY_PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.